Juan Andres - Jun 8, 2022 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Technical Operations and Quality Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Jun 8, 2022
Transactions value $
-$1,294,921
Form type
4
Date filed
6/10/2022, 04:08 PM
Previous filing
Jun 1, 2022
Next filing
Jun 13, 2022
SEC
View on sec.gov

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -1.37K -0.54% $0.00 253K Jun 8, 2022 Common Stock 1.37K $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -2K -0.79% $0.00 251K Jun 8, 2022 Common Stock 2K $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -2K -0.8% $0.00 249K Jun 8, 2022 Common Stock 2K $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -2K -0.8% $0.00 247K Jun 8, 2022 Common Stock 2K $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -2K -0.81% $0.00 245K Jun 8, 2022 Common Stock 2K $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -629 -100% $0.00* 0 Jun 8, 2022 Common Stock 629 $14.22 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021.
F2 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F3 This option is fully vested and exercisable.

Remarks:

Chief Technical Operations and Quality Officer